The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Protein Oxidation and Lipid Peroxidation in Brain of Subjects with Alzheimer's Disease: Insights into Mechanism of Neurodegeneration from Redox Proteomics
Abstract
Alzheimer's disease (AD), the leading cause of dementia, involves regionalized neuronal death, synaptic loss, and an accumulation of intraneuronal, neurofibrillary tangles and extracellular senile plaques. Although the initiating causes leading to AD are unknown, a number of previous studies reported the role of oxidative stress in AD brain. Postmortem analysis of AD brain showed elevated markers of oxidative stress including protein nitrotyrosine, carbonyls in proteins, lipid oxidation products, and oxidized DNA bases. In this review, we focus our attention on the role of protein oxidation and lipid peroxidation in the pathogenesis of AD. Particular attention is given to the current knowledge about the redox proteomics identification of oxidatively modified proteins in AD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–230 of 230
Apolipoprotein E genotypes and age of onset in early‐onset familial Alzheimer's disease
Levy‐Lahad, E., Lahad, A., Wijsman, E. M., Bird, T. D., & Schellenberg, G. D. (1995) · Annals of Neurology · doi:10.1002/ana.410380420 · Cited by 73
Soluble NSF-attachment proteins
Stenbeck, G. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00064-2 · Cited by 72
Glucose intolerance, cognitive impairment and Alzheimer’s disease
Vanhanen, M., & Soininen, H. S. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199812000-00011 · Cited by 72
Rapoport, S. I. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014174 · Cited by 69
Tyrosine Nitration Impairs Mammalian Aldolase A Activity
Koeck, T., Levison, B. S., Hazen, S. L., Crabb, J. W., Stuehr, D. J., & Aulak, K. S. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300141-mcp200 · Cited by 68
Lipoproteins and lipid peroxidation in Alzheimer's disease.
Bassett, C. N., & Montine, T. J. (2003) · PubMed · Cited by 66
Tilleman, K., Stevens, I., Spittaels, K., den Haute, C. V., Clerens, S., den Bergh, G. V., Geerts, H., LEUVEN, F. V., Vandesande, F., & Moens, L. J. (2002) · PROTEOMICS · doi:10.1002/1615-9861(200201)2:1<94::aid-prot94>3.0.co;2-w · Cited by 63
Alzheimer amyloid β‐peptides exhibit ionophore‐like properties in human erythrocytes
Engström, I., Ronquist, G. K., Pettersson, L., & Waldenström, A. P. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01732.x · Cited by 62
Guillaume, D., Bertrand, P., Dea, D., Davignon, J., & Poirier, J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062410.x · Cited by 61
Challenging the Cholinergic Hypothesis in Alzheimer Disease
Davies, P. (1999) · JAMA · doi:10.1001/jama.281.15.1433 · Cited by 60
Prostaglandin H2 (PGH2) accelerates formation of amyloid β1−42 oligomers
Boutaud, O. G., Ou, J. J., Chaurand, P., Caprioli, R. M., Montine, T. J., & Oates, J. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01064.x · Cited by 58
Lovell, M. A., Xiong, S., Markesbery, W. R., & Lynn, B. C. (2005) · Neurochemical Research · doi:10.1007/s11064-004-9692-5 · Cited by 57
Genetic causes of Parkinson?s disease: UCHL-1
Healy, D. G., Abou‐Sleiman, P. M., & Wood, N. W. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0917-3 · Cited by 57
Oxidative Stress and Neurodegeneration in Prion Diseases
Kim, J., Choi, S., Kim, N., Jin, J., Choi, E., Carp, R. I., & Kim, Y. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05648.x · Cited by 55
Song, B. J., Soh, Y., Bae, M., Pie, J., Wan, J., & Jeong, K.-S. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00247-7 · Cited by 54
New insights into genetic and molecular mechanisms of brain degeneration in tauopathies
Forman, M. S., Lee, V. M. ‐., & Trojanowski, J. Q. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00100-9 · Cited by 46
Enhancement of β‐Amyloid Peptide Aβ(1–40)‐Mediated Neurotoxicity by Glutamine Synthetase
Aksenov, M. Y., Aksenova, M. V., Harris‐White, M. E., Hensley, K., Butterfield, D. A., & Carney, J. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65041899.x · Cited by 40
Self-citationApolipoprotein E in the genetics and epidemiology of Alzheimer's disease
Hardy, J. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320600519 · Cited by 39
Differential Regulation of Glutamate Receptors in Alzheimer’s Disease
Lee, H., Zhu, X., Ghanbari, H. A., Ogawa, O., Raina, A. K., O'Neill, M. J., Perry, G. L., & Smith, M. A. (2002) · Neurosignals · doi:10.1159/000067427 · Cited by 37
DNA adducts of alpha,beta-unsaturated aldehydes and dicarbonyl compounds.
Marnett, L. J. (1994) · PubMed · Cited by 36
Ueno, I., Sakai, T., Yamaoka, M., Yoshida, R., & Tsugita, A. (2000) · Electrophoresis · Cited by 35
Oxidation-Dependent Changes in the Stability and Permeability of Lipid Bilayers
Anzai, K., Ogawa, K., Goto, Y., Senzaki, Y., Ozawa, T., & Yamamoto, H. (1999) · Antioxidants and Redox Signaling · doi:10.1089/ars.1999.1.3-339 · Cited by 35
Kato, Y., Hamajima, N., Inagaki, H., Okamura, N., Koji, T., Sasaki, M., & Nonaka, M. (1998) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199809)51:1<105::aid-mrd13>3.0.co;2-6 · Cited by 35
Molina, J. A., de Bustos, F., Jiménez‐Jiménez, F. J., Benito‐León, J., Gasalla, T., Pareja, M. O., Vela, L., Bermejo, F., Martín, M. A., Campos, Y., et al. (1997) · Neurology · doi:10.1212/wnl.48.3.636 · Cited by 33
González, C., Farias, G. A., & Maccioni, R. B. (1998) · PubMed · Cited by 30
Hippocampal damage and cytoskeletal disruption resulting from impaired energy metabolism
Geddes, J. W., Pang, Z., & Wiley, D. H. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815206 · Cited by 27
Oxidative stress in clinical situations - fact or fiction?
Pincemail, J., Defraigne, J.-O., & Limet, R. (1996) · European Journal of Anaesthesiology · doi:10.1046/j.1365-2346.1996.00979.x · Cited by 27
Emerging Pathogenic Role for Cyclin Dependent Kinases in Neurodegeneration
Smith, P. D., O'Hare, M. J., & Park, D. S. (2004) · Cell Cycle · doi:10.4161/cc.3.3.706 · Cited by 26
Dhitavat, S., Rivera, E. R., Rogers, E. J., & Shea, T. B. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3602 · Cited by 24
Mazur‐Kolecka, B., Kowal, D., Sukontasup, T., Dickson, D. W., & Frackowiak, J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03026-9 · Cited by 21
Cited by
Ighodaro, O. M., & Akinloye, O. A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 3,939
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Lipid peroxidation: Physiological levels and dual biological effects
Niki, E. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.032 · Cited by 1,006
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans
Marrocco, I., Altieri, F., & Peluso, I. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6501046 · Cited by 855
Metadata
- Authors
- Sultana, R., Perluigi, M., & Butterfield, D. A.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2006-11
- Volume
- 8
- Issue
- 11-12
- Pages
- 2021-2037
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W1978308357
- Cited by
- 262
- References
- 230
- FWCI
- 12.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.